Download PDF
Planta Med 2014; 80(05): 387-392
DOI: 10.1055/s-0034-1368265
Biological and Pharmacological Activity
Original Papers
Georg Thieme Verlag KG Stuttgart · New York

Effect of Icariin on UDP-Glucuronosyltransferases in Mouse Liver

Shang-Fu Xu
1   Key Laboratory for Basic Pharmacology of the Ministry of Education, Department of Pharmacology, Zunyi Medical College, Zunyi, China
,
Tao Jin
1   Key Laboratory for Basic Pharmacology of the Ministry of Education, Department of Pharmacology, Zunyi Medical College, Zunyi, China
,
Yuan-Fu Lu
1   Key Laboratory for Basic Pharmacology of the Ministry of Education, Department of Pharmacology, Zunyi Medical College, Zunyi, China
,
Li-Sheng Li
1   Key Laboratory for Basic Pharmacology of the Ministry of Education, Department of Pharmacology, Zunyi Medical College, Zunyi, China
,
Jie Liu
1   Key Laboratory for Basic Pharmacology of the Ministry of Education, Department of Pharmacology, Zunyi Medical College, Zunyi, China
2   University of Kansas Medical Center, Kansas City, KS, USA
,
Jing-Shan Shi
1   Key Laboratory for Basic Pharmacology of the Ministry of Education, Department of Pharmacology, Zunyi Medical College, Zunyi, China
› Author Affiliations
Further Information

Publication History

received 19 December 2013
revised 19 February 2014

accepted 21 February 2014

Publication Date:
07 April 2014 (online)

Also available at
    Permissions and Reprints

Abstract

Icariin is a flavonol glycoside isolated from Epimedium genus and has been used in the treatment of sexual dysfunction and osteoporosis. Our laboratory has shown that icariin is beneficial in brain disorders and cardiovascular diseases. Since icariin is widely used with other herbs and drugs, to understand its potential herb-drug interactions is of importance. Recently, icariin was shown to inhibit UDP-glucuronosyltransferases, particularly the Ugt1 family enzymes in vitro, but little is known about such effects in vivo. This study investigated the effects of icariin on the expression of UDP-glucuronosyltransferases and cytochrome P450 enzymes in the livers of mice. Adult mice were treated with icariin at doses of 0, 40, 80, 160, and 320 mg/kg, p. o., for 7 days. Phenobarbital (120 mg/kg, p. o.) and rifampin (360 mg/kg, p. o.) were given twice daily for 3 days as positive controls. The livers were removed to determine UDP-glucuronosyltransferase activity and total RNA isolation. The UDP-glucuronosyltransferase activities towards 2-aminophenol were basically unaltered by the treatments. The expression of Cyp2b10 was increased 35-fold by phenobarbital, and Cyp3a11 was increased 4.5-fold by rifampin. Icariin did not affect Cyp2b10 and Cyp3a11 expression, but unexpectedly increased Cyp4a14 expression. Both phenobarbital and rifampin increased Ugt1a1, Ugt1a6, Ugt1a9, and icariin but did not show any suppressive effects on the Ugt1 family genes. Icariin at the highest dose (320 mg/kg) slightly increased Ugt2b1, Ugt2b5, and Ugt2b36. These findings indicate that icariin did not suppress UDP-glucuronosyltransferase expression, instead, it increased the mRNA of Cyp4a14 and slightly increased Ugt2b isoforms in mouse livers.

Key words

icariiin - phenobarbital - rifampin - cytochrome P450 - UDP-glucuronosyltransferase
 

  • References

  • 1 de Lima Toccafondo Vieira M, Huang SM. Botanical-drug interactions: a scientific perspective. Planta Med 2012; 78: 1400-1415
    Thieme ConnectPubMedSearch in Google Scholar
  • 2 Zhou X, Chan K, Yeung JH. Herb-drug interactions with Danshen (Salvia miltiorrhiza): a review on the role of cytochrome P450 enzymes. Drug Metabol Drug Interact 2012; 27: 9-18
    PubMedSearch in Google Scholar
  • 3 Zhu QN, Zhang D, Jin T, Wu Q, Liu J, Lu YF. Rutaecarpine effects on expression of hepatic phase-1, phase-2 metabolism and transporter genes as a basis of herb-drug interactions. J Ethnopharmacol 2013; 147: 215-219
    CrossrefPubMedSearch in Google Scholar
  • 4 Han HK. Role of transporters in drug interactions. Arch Pharm Res 2011; 34: 1865-1877
    CrossrefPubMedSearch in Google Scholar
  • 5 Li L, Hu H, Xu S, Zhou Q, Zeng S. Roles of UDP-glucuronosyltransferases in phytochemical metabolism of herbal medicines and the associated herb-drug interactions. Curr Drug Metab 2012; 13: 615-623
    CrossrefPubMedSearch in Google Scholar
  • 6 Gong QH, Yang DL, Shi JS, Ding LJ, Liu B, Li LS. Advances in neuroharmacological effects and molecular mechanisms of icariin. Chin J New Drugs Clin Remedies 2011; 30: 481-486
    PubMedSearch in Google Scholar
  • 7 Kang HK, Choi YH, Kwon H, Lee SB, Kim DH, Sung CK, Park YI, Dong MS. Estrogenic/antiestrogenic activities of a Epimedium koreanum extract and its major components: in vitro and in vivo studies. Food Chem Toxicol 2012; 50: 2751-2759
    CrossrefPubMedSearch in Google Scholar
  • 8 Kapoor S. Icariin and its emerging role in the treatment of osteoporosis. Chin Med J (Engl) 2013; 126: 400-404
    PubMedSearch in Google Scholar
  • 9 Li L, Zhou QX, Shi JS. Protective effects of icariin on neurons injured by cerebral ischemia/reperfusion. Chin Med J (Engl) 2005; 118: 1637-1643
    PubMedSearch in Google Scholar
  • 10 Luo Y, Nie J, Gong QH, Lu YF, Wu Q, Shi JS. Protective effects of icariin against learning and memory deficits induced by aluminium in rats. Clin Exp Pharmacol Physiol 2007; 34: 792-795
    CrossrefPubMedSearch in Google Scholar
  • 11 Xu RX, Wu Q, Luo Y, Gong QH, Yu LM, Huang XN, Sun AS, Shi JS. Protective effects of icariin on cognitive deficits induced by chronic cerebral hypoperfusion in rats. Clin Exp Pharmacol Physiol 2009; 36: 810-815
    CrossrefPubMedSearch in Google Scholar
  • 12 Li F, Gong QH, Wu Q, Lu YF, Shi JS. Icariin isolated from Epimedium brevicornum Maxim attenuates learning and memory deficits induced by d-galactose in rats. Pharmacol Biochem Behav 2010; 96: 301-305
    CrossrefPubMedSearch in Google Scholar
  • 13 Nie J, Luo Y, Huang XN, Gong QH, Wu Q, Shi JS. Icariin inhibits beta-amyloid peptide segment 25–35 induced expression of beta-secretase in rat hippocampus. Eur J Pharmacol 2010; 626: 213-218
    CrossrefPubMedSearch in Google Scholar
  • 14 Guo J, Li F, Wu Q, Gong Q, Lu Y, Shi J. Protective effects of icariin on brain dysfunction induced by lipopolysaccharide in rats. Phytomedicine 2010; 17: 950-955
    CrossrefPubMedSearch in Google Scholar
  • 15 Jin F, Gong QH, Xu YS, Wang LN, Jin H, Li F, Li LS, Ma YM, Shi JS. Icariin, a phosphodiesterase-5 inhibitor, improves learning and memory in APP/PS1 transgenic mice by stimulation of NO/cGMP signalling. Int J Neuropsychopharmacol 2014; 11: 1-11
    PubMedSearch in Google Scholar
  • 16 Wang M, Sun AS, Wu Q, Yu LM, Xie XL, Gong Q-H, Shi JS. Effects of icariin on the contents of liver microsomal cytochrome P450 and the activities of CYP2E1. West China J Pharmaceut Sci 2009; 24: 101-104
    PubMedSearch in Google Scholar
  • 17 Li LS, Chen L, Wang AB, Lu YF, Liu J, Shi JS. Effects of icariin on liver microsomal cytochrome P450 in rats with different ages. West China J Pharmaceut Sci 2011; 27: 376-378
    PubMedSearch in Google Scholar
  • 18 Li Z, Cheung FS, Zheng J, Chan T, Zhu L, Zhou F. Interaction of the bioactive flavonol, icariin, with the essential human solute carrier transporters. J Biochem Mol Toxicol 2014; 28: 91-97
    CrossrefPubMedSearch in Google Scholar
  • 19 Wu LX, Guo CX, Qu Q, Yu J, Chen WQ, Wang G, Fan L, Li Q, Zhang W, Zhou HH. Effects of natural products on the function of human organic anion transporting polypeptide 1B1. Xenobiotica 2012; 42: 339-348
    CrossrefPubMedSearch in Google Scholar
  • 20 Cao YF, He RR, Cao J, Chen JX, Huang T, Liu Y. Drug-drug interactions potential of icariin and its intestinal metabolites via inhibition of intestinal UDP-glucuronosyltransferases. Evid Based Complement Alternat Med 2012; 2012: 395912
    PubMedSearch in Google Scholar
  • 21 Li LS, Liu J, Wang AB, Chen L, Lu YF, Liu J. Effects of icariin on hepatic phase II drug metabolism enzymes and transporters in rats of different age. Acta Acad Med Zunyi 2012; 35: 13-16
    PubMedSearch in Google Scholar
  • 22 Rowland A, Miners JO, Mackenzie PI. The UDP-glucuronosyltransferases: their role in drug metabolism and detoxification. Int J Biochem Cell Biol 2013; 45: 1121-1132
    CrossrefPubMedSearch in Google Scholar
  • 23 Klaassen CD. Learning to program the liver. Annu Rev Pharmacol Toxicol 2014; 54: 1-8
    CrossrefPubMedSearch in Google Scholar
  • 24 Buckley DB, Klaassen CD. Induction of mouse UDP-glucuronosyltransferase mRNA expression in liver and intestine by activators of aryl-hydrocarbon receptor, constitutive androstane receptor, pregnane X receptor, peroxisome proliferator-activated receptor alpha, and nuclear factor erythroid 2-related factor 2. Drug Metab Dispos 2009; 37: 847-856
    CrossrefPubMedSearch in Google Scholar
  • 25 Aleksunes LM, Klaassen CD. Coordinated regulation of hepatic phase I and II drug-metabolizing genes and transporters using AhR-, CAR-, PXR-, PPARα-, and Nrf2-null mice. Drug Metab Dispos 2012; 40: 1366-1379
    CrossrefPubMedSearch in Google Scholar
  • 26 Buckley DB, Klaassen CD. Tissue- and gender-specific mRNA expression of UDP-glucuronosyltransferases (UGTs) in mice. Drug Metab Dispos 2007; 35: 121-127
    PubMedSearch in Google Scholar
  • 27 Zhang WP, Bai XJ, Zheng XP, Xie XL, Yuan ZY. Icariin attenuates the enhanced prothrombotic state in atherosclerotic rabbits independently of its lipid-lowering effects. Planta Med 2013; 79: 731-736
    Thieme ConnectPubMedSearch in Google Scholar
  • 28 Mackenzie PI, Owens IS, Burchell B, Bock KW, Bairoch A, Bélanger A, Fournel-Gigleux S, Green M, Hum DW, Iyanagi T, Lancet D, Louisot P, Magdalou J, Chowdhury JR, Ritter JK, Schachter H, Tephly TR, Tipton KF, Nebert DW. The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics 1997; 7: 255-269
    CrossrefPubMedSearch in Google Scholar
  • 29 Owens IS, Basu NK, Banerjee R. UDP-glucuronosyltransferases: gene structures of UGT1 and UGT2 families. Methods Enzymol 2005; 400: 1-22
    CrossrefPubMedSearch in Google Scholar